Antiphospholipid syndrome is a rare autoimmune disease characterized by a high tendency
of developing thrombotic events. It is diagnosed in the presence of specific laboratory …

… of the clinical experience of an … Antiphospholipid syndrome without antiphospholipid
antibodies at the time of the thrombotic event: transient 'seronegative' antiphospholipid syndrome?. …

… directed against proteins that bind to phospholipid. Antiphospholipid antibody syndrome (APS)
refers to the association between antiphospholipid antibodies and thrombosis risk or …

Antiphospholipid syndrome (APS) is an autoimmune disease characterized by venous or
arterial thrombosis and/or adverse pregnancy outcomes. Recurrent miscarriage, fetal death, …

… Antiphospholipid syndrome (APS) is a systemic autoimmune … have persistent antiphospholipid
antibodies. Catastrophic … Based on our experience, most patients with CAPS have aPL …

… Catastrophic antiphospholipid syndrome (CAPS) is a life-threatening variant seen in … In
our experience, a multidisciplinary approach, with regular meetings involving neurology, …

… The importance of the goal to provide optimal care is highlighted by the potentially severe
and life-threatening complications that APS patients can experience, as a result of thrombotic, …

Objectives The antiphospholipid syndrome (APS) is an autoimmune disease associated
with thrombotic and non-thrombotic neurologic manifestations. APS is classified as primary (…

Persistent serum positivity for antiphospholipid antibodies (aPL) is required to diagnose
antiphospholipid syndrome (APS), an autoimmune disease characterized by recurrent vascular …

… The treatment of thrombosis in patients with antiphospholipid syndrome (APS) usually
requires long-term anticoagulation with vitamin K antagonists. The effectiveness of direct oral …